KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vir Biotechnology (VIR) Interest & Investment Income (2018 - 2025)

Vir Biotechnology's Interest & Investment Income history spans 6 years, with the latest figure at $7.8 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 44.87% to $7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $40.2 million, a 43.97% decrease, with the full-year FY2025 number at $40.2 million, down 43.97% from a year prior.
  • Interest & Investment Income hit $7.8 million in Q4 2025 for Vir Biotechnology, down from $9.4 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for VIR hit a ceiling of $21.9 million in Q3 2023 and a floor of $7.8 million in Q4 2025.
  • Historically, Interest & Investment Income has averaged $15.5 million across 3 years, with a median of $15.8 million in 2024.
  • Biggest five-year swings in Interest & Investment Income: fell 20.08% in 2024 and later crashed 46.58% in 2025.
  • Tracing VIR's Interest & Investment Income over 3 years: stood at $20.7 million in 2023, then crashed by 31.75% to $14.2 million in 2024, then plummeted by 44.87% to $7.8 million in 2025.
  • Business Quant data shows Interest & Investment Income for VIR at $7.8 million in Q4 2025, $9.4 million in Q3 2025, and $10.8 million in Q2 2025.